Literature DB >> 518552

The role of disulphide bonds in human intestinal mucin.

J F Forstner, I Jabbal, R Qureshi, D I Kells, G G Forstner.   

Abstract

Goblet-cell mucin (mucin 1) was isolated and purified from human small-intestinal scrapings. After application of mucin 1 to DEAE-Bio-Gel (A) columns, most of the glycoprotein (76-94% of hexoses) was eluted in the first peak (designated mucin 2). Minor amounts of acidic glycoproteins were eluted with 0.2m- and 0.4m-NaCl in later peaks. Analyses of mucin 1 and mucin 2 revealed mucin 2 to be a monodisperse highly glycosylated glycoprotein containing 6.3% by wt. of protein, N-acetylgalactosamine, N-acetylglucosamine, galactose and fucose. Mucin 1 was similar in composition, but was polydisperse and contained more protein (12.3% by wt.) as well as N-acetylneuraminic acid. Analytical CsCl-gradient ultracentrifugation showed both mucin 1 and mucin 2 to have a major component with an average buoyant density of 1.47000g/ml. Mucin 1 also contained a slightly less-dense minor glycoprotein component. After exhaustive reduction and alkylation mucin 1 retained its major component, but partly dissociated into two lighter glycoprotein components. Mucin 2, in contrast, did not change its density distribution after reduction. Band ultracentrifugation in (2)H(2)O-containing iso-osmotic buffers showed that mucin 1 contained a major fast-sedimenting component (s(o)=37+/-2S), and a minor amount of a slower-sedimenting component. After reduction there was an increased quantity of the latter component, for which an s(o) value of 14.5S was calculated. In contrast, mucin 2 was unaltered by reduction (s(o)=33+/-2S). These findings indicate that the major component of goblet-cell mucin (mucin 2) does not dissociate after S-S-bond reduction, and thus does not apparently rely for its polymeric structure on the association of subunits through covalent disulphide bonds. However, the effects of reduction on mucin 1 suggest that in the native mucin intramolecular disulphide bonds in the minor glycoproteins may stabilize their structure, permitting secondary non-covalent interactions to develop with the major dense mucin (mucin 2) protein.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518552      PMCID: PMC1161213          DOI: 10.1042/bj1810725

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Purification, composition, molecular weight, and subunit structure of ovine submaxillary mucin.

Authors:  H D Hill; J A Reynolds; R L Hill
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

Review 3.  Principles of biopolymer gelation. Possible models for mucus gel structure.

Authors:  E R Morris; D A Rees
Journal:  Br Med Bull       Date:  1978-01       Impact factor: 4.291

Review 4.  Constituents of mucus and their separation.

Authors:  J M Creeth
Journal:  Br Med Bull       Date:  1978-01       Impact factor: 4.291

Review 5.  The determination of carbohydrate in biological materials by gas-liquid chromatography.

Authors:  J R Clamp; T Bhatti; R E Chambers
Journal:  Methods Biochem Anal       Date:  1971

6.  The isolation and characterization of the high-molecular-weight glycoprotein from pig colonic mucus.

Authors:  T Marshall; A Allen
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

7.  Chemical aspects of mucus. General considerations.

Authors:  J R Clamp
Journal:  Br Med Bull       Date:  1978-01       Impact factor: 4.291

8.  Biochemical definition of human tracheobronchial mucus.

Authors:  P Roussel; P Degand; G Lamblin; A Laine; J J Lafitte
Journal:  Lung       Date:  1978       Impact factor: 2.584

9.  An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials.

Authors:  R E Chambers; J R Clamp
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

10.  The separation and characterization of bronchial glycoproteins by density-gradient methods.

Authors:  J M Creeth; K R Bhaskar; J R Horton; I Das; M T Lopez-Vidriero; L Reid
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

View more
  9 in total

1.  Purification and characterization of goblet-cell mucin of high Mr from the small intestine of sheep.

Authors:  T K Mukkur; D L Watson; K S Saini; A K Lascelles
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

2.  Antigenic and structural features of goblet-cell mucin of human small intestine.

Authors:  M Mantle; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

3.  Cloning and analysis of human gastric mucin cDNA reveals two types of conserved cysteine-rich domains.

Authors:  L W Klomp; L Van Rens; G J Strous
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

4.  Heterogeneity of rat goblet-cell mucin before and after reduction.

Authors:  R E Fahim; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

5.  Age-related changes in chemical composition and physical properties of mucus glycoproteins from rat small intestine.

Authors:  M D Shub; K Y Pang; D A Swann; W A Walker
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

6.  Polymeric structure of pig small-intestinal mucus glycoprotein. Dissociation by proteolysis or by reduction of disulphide bridges.

Authors:  M Mantle; D Mantle; A Allen
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

7.  Isolation and characterization of the native glycoprotein from pig small-intestinal mucus.

Authors:  M Mantle; A Allen
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

8.  Purification and immunofluorescent localization of rat submandibular mucin.

Authors:  N Fleming; M Brent; R Arellano; J F Forstner
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

9.  Yersinia enterocolitica palearctica serobiotype O:3/4--a successful group of emerging zoonotic pathogens.

Authors:  Julia Batzilla; Uladzimir Antonenka; Dirk Höper; Jürgen Heesemann; Alexander Rakin
Journal:  BMC Genomics       Date:  2011-07-06       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.